Showing results (611-620 of 635) with videos related to

Sort By:
Pageof 64
Physical Review Letters|February 6, 2025
First Direct Search for Light Dark Matter Using the NEON Experiment at a Nuclear ReactorJ J Choi, C Ha, E J Jeon, et al.
Clinical Genitourinary Cancer|July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial designG R Pond, J Bellmunt, J E Rosenberg, et al.
Nature Communications|January 5, 2021
Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASHJinrui Dong, Sivakumar Viswanathan, Eleonora Adami, et al.
Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic ExperienceCorey J Hobbs, Stephen J Ko, Nitesh N Paryani, et al.
Scientific Reports|October 21, 2020
Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse modelsWei-Wen Lim, Ben Corden, Benjamin Ng, et al.
The Lancet. Oncology|February 16, 2015
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyJenny J Ko, Wanling Xie, Nils Kroeger, et al.
British Journal of Cancer|April 3, 2014
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDCJ J Ko, T K Choueiri, B I Rini, et al.
Advances in Radiation Oncology|July 26, 2017
Patient-reported distress and survival among patients receiving definitive radiation therapyYacob Habboush, Robert P Shannon, Shehzad K Niazi, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
Pageof 64